Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inqaba Biotechnical Industries, commonly known as inqaba biotec, is a South African life sciences and genomics company providing sequencing, genotyping, bioinformatics, molecular diagnostics, and laboratory products across Sub-Saharan Africa. The company operates commercial genomics service laboratories and distributes a broad portfolio of life science consumables, instruments, reagents, and diagnostic products to academic, research, clinical, veterinary, agricultural, and industrial customers. Its service offerings include Sanger sequencing, next-generation sequencing, oligo synthesis, qPCR analysis, fragment analysis, MassARRAY genotyping, and animal genetics testing. Inqaba also supports molecular and clinical diagnostics, including infectious disease, oncology, prenatal, HLA, food safety, and veterinary testing solutions. The business appears to be primarily a commercial service and distribution platform rather than a therapeutics developer with a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inqaba Biotechnical Industries.